...
首页> 外文期刊>The Journal of Thoracic and Cardiovascular Surgery >Experimental safety and efficacy evaluation of an extracorporeal pumpless artificial lung in providing respiratory support through the axillary vessels.
【24h】

Experimental safety and efficacy evaluation of an extracorporeal pumpless artificial lung in providing respiratory support through the axillary vessels.

机译:体外无泵人工肺通过腋血管提供呼吸支持的实验安全性和功效评估。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVE: We sought to investigate the safety and feasibility of implanting the pumpless interventional lung assist device (Novalung; Novalung GmbH, Hechingen, Germany) to the axillary vessels either by means of direct cannulation or end-to-side graft interposition and the capability of either type of vascular access to provide respiratory support during apneic ventilation in adult pigs. METHODS: Ten pigs were ventilated for 4 hours (respiratory rate, 20-25 breaths/min; tidal volume, 10-12 mL/kg; fraction of inspired oxygen, 1.0; positive end-expiratory pressure, 5 cm H2O). Thereafter, the interventional lung assist device was surgically connected to the right axillary artery and vein by using direct cannulation (n = 5) or end-to-side ringed polytetrafluoroethylene graft interposition (n = 5), and ventilatory settings were reduced to achieve near apneic ventilation (respiratory rate, 4 breaths/min; tidal volume, 1-2 mL/kg; fraction of inspired oxygen, 1.0; positive end-expiratory pressure, 20 cm H2O).Hemodynamic and intrathoracic volumes and lung cytokine levels were measured. RESULTS: Blood flow through the interventional lung assist device was 1.7 +/- 0.4 L/min or 30% +/- 14% of the cardiac output, and the mean pressure gradient across the interventional lung assist device was 10 +/- 2 mm Hg. The interventional lung assist device allowed an O2 transfer of 225.7 +/- 70 mL/min and a CO2 removal of 261.7 +/- 28.5 mL/min. Although the amount of blood flow perfusing the interventional lung assist device was significantly higher (P < .01) with direct cannulation (2.1 +/- 0.3 L/min) compared with that seen in graft interposition (1.3 +/- 0.3 L/min), the latter allowed similar respiratory support with reduced hemodynamic instability. CONCLUSIONS: The axillary vessels are a safe and attractive cannulation site for pumpless partial respiratory support. Compared with direct cannulation, graft interposition was equally able to support the interventional lung assist device-driven gas exchange requirements during apneic ventilation with better hemodynamic stability.
机译:目的:我们试图研究通过直接插管或端侧移植物植入将无泵介入式肺辅助装置(Novalung; Novalung GmbH,Hechingen,德国)植入腋窝血管的安全性和可行性以及在成年猪的呼吸暂停通气中,两种血管通路均可提供呼吸支持。方法:十只猪通气4小时(呼吸频率20-25呼吸/分钟;潮气量10-12 mL / kg;吸氧分数:1.0;呼气末正压,5 cm H2O)。此后,通过直接插管(n = 5)或端侧环状聚四氟乙烯移植物插管(n = 5),将介入性肺辅助装置通过外科手术连接到右腋动脉和静脉,并降低通气设置以达到接近呼吸通气(呼吸频率,4次呼吸/分钟;潮气量,1-2 mL / kg;吸氧分数,1.0;呼气末正压,20 cm H2O)测量血流动力学和胸腔内容积以及肺细胞因子水平。结果:通过介入肺辅助设备的血流量为心输出量的1.7 +/- 0.4 L / min或心输出量的30%+/- 14%,通过介入肺辅助设备的平均压力梯度为10 +/- 2 mm汞介入性肺辅助装置允许以225.7 +/- 70 mL / min的速度传输O2,以261.7 +/- 28.5 mL / min的速度传输CO2。尽管直接插管(2.1 +/- 0.3 L / min)灌注的介入肺辅助装置的血流量显着高于移植物插入(1.3 +/- 0.3 L / min)(P <.01) ),后者可以提供类似的呼吸支持,从而减少血液动力学不稳定。结论:腋窝血管是用于无泵部分呼吸支持的安全且引人注目的插管部位。与直接插管相比,移植物插置同样能够在呼吸暂停通气期间支持介入性肺辅助设备驱动的气体交换需求,并具有更好的血液动力学稳定性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号